Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Glial Cell Development and Function in Zebrafish.
IL-17: A new actor in IFN-driven systemic autoimmune diseases.
Weekly multimodal MRI follow-up of two multiple sclerosis active lesions presenting a transient decrease in ADC.
The Deleterious Effects of Oxidative and Nitrosative Stress on Palmitoylation, Membrane Lipid Rafts and Lipid-Based Cellular Signalling: New Drug Targets in Neuroimmune Disorders.
Sphingolipids in neuroinflammation.
Beneficial effects of Rituximab in patients with anti-MAG (myelin-associated glycoprotein) neuropathy: case reports.
A dam for retrograde axonal degeneration in multiple sclerosis?
Monitoring neuromyelitis optica activity.
Demyelination and other neurological adverse events after anti-TNF therapy.
Cerebrospinal Fluid High-Mobility Group Box Protein 1 in Neuromyelitis Optica and Multiple Sclerosis.
Contingent negative variation is associated with cognitive dysfunction and secondary progressive disease course in multiple sclerosis.
Infusion of Sulfosuccinimidyl-4-[N-maleimidomethyl]cyclohexane-1-carboxylate-Conjugated MOG35-55-Coupled Spleen Cells Effectively Prevents and Reverses Experimental Autoimmune Encephalomyelitis in Mice.
Neural Plasticity in Multiple Sclerosis: The Functional and Molecular Background.
Quality improvement and practice-based research in neurology using the electronic medical record.
Defining the new end point for multiple sclerosis treatment.
A Biodegradable Nanoparticle Platform for the Induction of Antigen-Specific Immune Tolerance for Treatment of Autoimmune Disease.
Identification and Characterization of FTY720 for the Treatment of Human African Trypanosomiasis.
Impact of delayed diagnosis and treatment in clinically isolated syndrome and multiple sclerosis.
Effects of Three Months Fingolimod Therapy on Heart Rate.
Ciliary Neurotrophic Factor Role in Myelin Oligodendrocyte Glycoprotein Expression in Cuprizone-Induced Multiple Sclerosis Mice.
Circadian rhythm sleep disorders in patients with multiple sclerosis and its association with fatigue: A case-control study.
Coenzyme Q10 as a treatment for fatigue and depression in multiple sclerosis patients: A double blind randomized clinical trial.
Residential Distance to High-voltage Power Lines and Risk of Neurodegenerative Diseases: a Danish Population-based Case-Control Study.
Latin American algorithm for treatment of relapsing-remitting multiple sclerosis using disease-modifying agents.
Effects of vitamin D on retinal nerve fiber layer in vitamin D deficient patients with optic neuritis: Preliminary findings of a randomized, placebo-controlled trial.
Pages
« first
‹ previous
…
274
275
276
277
278
279
280
281
282
…
next ›
last »